# Stemtech Corporation (STEK)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/STEK/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 2.48M | $ -2.62M | $ -625.2K | $ 2.36M | $ -5.80M |
| 2024 | $ 5.31M | $ -3.96M | $ -631.9K | $ 3.82M | $ -4.48M |
| 2023 | $ 5.32M | $ -5.87M | $ -2.19M | $ 3.70M | $ -2.04M |
| 2022 | $ 5.09M | $ -9.94M | $ -1.36M | $ 1.29M | $ -2.43M |
| 2021 | $ 5.14M | $ -8.41M | $ -2.28M | $ 1.45M | $ -3.36M |
| 2020 | $ 6.57M | $ -1.08M | $ -490.7K | $ 888.6K | $ 1.88M |
| 2019 | N/A | N/A | N/A | $ 30.0K | $ -198.0K |
| 2018 | N/A | N/A | N/A | $ 30.0K | $ -164.0K |
| 2017 | N/A | N/A | N/A | $ 101.8K | $ -120.3K |
| 2016 | N/A | N/A | N/A | $ 80.5K | $ -94.0K |
| 2015 | N/A | N/A | N/A | $ 40.0K | $ -65.6K |
| 2014 | N/A | N/A | N/A | $ 30.0K | $ 0 |
| 2013 | N/A | N/A | N/A | $ 20.0K | $ -34.2K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.41 |
| Liabilities / Eq | -1.78 |
| Current Ratio | 0.10 |

## Other views

- [Metrics](https://sponda.capital/en/STEK.md)
- [Charts](https://sponda.capital/en/STEK/charts.md)
- [Compare](https://sponda.capital/en/STEK/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.